Targanta Therapeutics Corp.·4

Feb 27, 4:08 PM ET

Gordon Eric M 4

4 · Targanta Therapeutics Corp. · Filed Feb 27, 2009

Insider Transaction Report

Form 4
Period: 2009-02-25
Transactions
  • Disposition from Tender

    Common Stock

    2009-02-2512,5990 total(indirect: See footnote.)
  • Disposition from Tender

    Common Stock

    2009-02-251,699,3110 total(indirect: See footnote.)
  • Disposition from Tender

    Common Stock

    2009-02-25505,9980 total(indirect: See footnote.)
Footnotes (4)
  • [F1]The shares were tendered in a tender offer by Boxford Subsidiary Corporation for consideration of (1) $2.00 per common share in cash, plus (2) the contractual right to receive up to an additional $4.55 per common share in contingent cash payments if specified regulatory and commercial milestones are achieved within agreed upon time periods.
  • [F2]Shares held by Skyline Venture Partners III, L.P., whose General Partner is Skyline Venture Management III, LLC. John Freund and Yasunori Kaneko, as Managing Directors of Skyline Venture Management III, LLC, may be deemed to share voting and dispositive power with respect to all common stock and warrants to purchase common stock held by Skyline affiliated entities. In addition, Eric Gordon is a partner at Skyline ventures, and as such has influence in the voting and investment power of these shares, although he has no direct power. Each of Drs. Freund, Kaneko and Gordon disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any.
  • [F3]Shares held by Skyline Venture Partners Qualified Purchaser Fund III, L.P., whose General Partner is Skyline Venture Management III, LLC. John Freund and Yasunori Kaneko, as Managing Directors of Skyline Venture Management III, LLC, may be deemed to share voting and dispositive power with respect to all common stock and warrants to purchase common stock held by Skyline affiliated entities. In addition, Eric Gordon is a partner at Skyline ventures, and as such has influence in the voting and investment power of these shares, although he has no direct power. Each of Drs. Freund, Kaneko and Gordon disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any.
  • [F4]Shares held by Skyline Venture Partners Qualified Purchaser Fund IV, L.P., whose General Partner is Skyline Venture Management IV, LLC. John Freund and Yasunori Kaneko, as Managing Directors of Skyline Venture Management IV, LLC, may be deemed to share voting and dispositive power with respect to all common stock and warrants to purchase common stock held by Skyline affiliated entities. In addition, Eric Gordon is a partner at Skyline ventures, and as such has influence in the voting and investment power of these shares, although he has no direct power. Each of Drs. Freund, Kaneko and Gordon disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any.

Documents

1 file
  • 4
    c81840_4x0.xmlPrimary

    MAIN DOCUMENT DESCRIPTION